Good afternoon, and welcome to Grown Rogue International Incorporated's third quarter 2026 earnings conference call. Please note that today's call is being recorded. Before we begin, management's remark and responses to questions may include forward-looking statements within the meaning of applicable Canadian and United States securities laws, including statements about guidance, expansion plans, proposed acquisitions, and future performance. These statements reflect management's current expectations and assumptions and are subject to risk and uncertainties that could cause actual results to differ materially.
Further information about this risk and assumption is available in today's earnings release and the company's filings on SEDAR+ and EDGAR. Listeners should not place undue reliance on these statements, which speak only as of today. Grown Rogue undertakes no obligation to update them, except as required by law. Management may also refer to non-GAAP financial measures and ratios, including EBITDA, Adjusted EBITDA, and Adjusted EBITDA margin.
These provide supplemental information, do not have standardized meanings under U.S. GAAP, and may not be comparable to similarly titled measures used by other companies. They should not be considered substitutes for GAAP results. Definitions and reconciliations of historical non-GAAP measures are included in today's earnings release, available at ir.grownrogue.com. Unless otherwise indicated, all financial amounts are in USD. I will turn the call over to Obie Strickler, Chief Executive Officer of Grown Rogue. Obie Strickler , please go ahead.
All right. Thank you very much, and thanks everyone for joining today. Some of you may be aware we're having what looks like a global outage in Outlook, Microsoft. Obviously shut down emails for the company today. Obviously got the press release out, we're having the conference call, all the filings are completed, just waiting on kind of email traffic to come back up, and then we'll get those filed for the Qs and all the different components that are coming along with that. Yeah, thanks for your patience, and a little bit out of our control. Had another solid quarter in Q3 in the midst of executing on our ambitious growth plans this year. As you can imagine, things are busy and a lot going on for the organization.
Wanted to take a few minutes to talk about some of the key milestones we've achieved since our last conference call. Starting in Minnesota, we pride ourselves on standing things up quickly, as time is money in so many ways. In the case of Minnesota, it's even more important, as we believe the market is significantly supply constrained, especially when it comes to indoor flower, let alone the craft quality indoor flower that we' re building our business on. Construction is materially complete for the first phase, which will start, as we've said in the past, with approximately 8,000 sq ft of flowering canopy. That should be producing around 500 pounds of whole flower per month. Each of the five flower rooms is populated inside the facility, and we're scheduled for our first harvest at the end of November.
With our crop schedule, we'll be starting to harvest out of that facility effectively every two weeks. Getting the team and our systems dialed in with the quality of our construction and the design that we put in place, just super excited about our ability to get this facility up to our standards in short order, looking forward to starting our sales in January of 2027.
New startup is always a scramble as usual, but excited how the existing team and the new team members we brought in are coming together with their planning and execution. As you know, in Minnesota, at full capacity with our licensing, we can increase our flowering canopy up to 30,000 sq ft, which we' ll obviously do in phases. We've begun starting the internal design work for the next phase of that construction.
That would take us up to probably the next phase of our growth, which would be about 16,000 sq ft of flower. Obviously, that will depend upon executing on that work, depending upon sell-through and the market demand. But considering the undersupply situation currently in Minnesota, what we're observing there, what other companies are talking about, very excited about the potential in this market.
Illinois, similar to Minnesota, really pleased with how quickly the team pulled this together and just how nimble we've been to address the issues with taking over an already built facility. We're now several harvests in and excited about the initial quality and the response to our brands in the marketplace as we begun selling back in October. It's important to note that Illinois is We look at this as a little bit of a slower build.
It does n't have the supply limitations, and we know we need to earn the shelf space in a market with larger, more vertical operators that control a significant portion of that market. Confident in our ability to be great partners, both to the large players and the independents across Illinois. Very confident and believe strongly that we bring a great quality and value proposition to the customers across our brand portfolio.
New Jersey, I mean, continues to be a great market for us, and what we're learning there is really informing our practices in new markets. Package sales continues to be effectively 100% of our production, which has been one of our goals and mandates since the beginning. We continue to have more demand than production, which bodes well for the three additional flower rooms we' re building to get to full capacity.
This will add another 6,000 sq ft of flowering canopy, which will translate our estimated yields to around 400 pounds per month of additional supply. We plan to populate these new flower rooms starting in December, and then into the first part of the year, to balance the new capacity against our monthly sales and really targeting the upswing you see after the slow winter months coming into spring, 4/20, things like that, where the demand starts to pick back up.
I think one important note, there is a lot of data sources out there. We rely upon Pistil, but Pistil data shows us as the number three brand in the state across our 3.5 g eighth category. When you include 7 g into that form factor, the number five brand in the state across the various brands that we have in that market.
Really exciting accomplishment for the team, and obviously makes us very hungry to improve those rankings as we move into 2027. I'll let Josh Rosen talk a little bit more about New York specifically, but similarly want to highlight how quickly mobilizing resources to revitalize PharmaCann's Hamptonburgh facility. The team is pushing, and thanks to all their hard work, I think all 15 indoor flower rooms are already populated with our first harvest scheduled for the middle of December. It is a monster facility, but at the speed at which the teams are executing, it has just been very, very impressive. Unlike Grown Rogue's kind of history, we' re not being incremental in New York with the amount of production that we're bringing online, which should be about 2,000 pounds per month of our high-quality indoor flower.
We got a lot of confidence in our ability to grow that based on what the team is doing already, and then more importantly, get it packaged and into the market effectively as we kind of navigate what the demand looks like there, the brands, just the ethos of that market as we get our arms around it. Again, first harvest will be in December. We expect to start sales in kind of mid-late January, early February. Also wanted to highlight just the appreciation for the PharmaCann team, going through what they have over the last couple years, but rolling with us through this massive effort that we're undertaking inside of New York. You find this, and we've talked about it before, but team highlights, right?
I just really want to take a moment to commend and thank our existing team for their hard work and stepping up over the last year. We were running really hard even before New York was kind of announced and we decided to take this on. Obviously was not on our bingo card this year, but was too special of an opportunity to pass up. We have super high standards and take great pride in our flower and products, and I want to acknowledge that we' re stretched a bit thin at the moment, but to a person inside of our team, that does not change our unwavering commitment and passion for producing great flower consistently.
Of course, none of this would be possible without some really strong recent additions to our squad over the last few months, coupled with individuals that have been with us for years and have really stepped into their new roles and are embracing kind of this new scale and opportunity that sits in front of us. In particular, I want to highlight Michael Johnson, who I've personally known for years.
We go way back and just never kind of been able to align on getting him to join Grown Rogue based upon his other roles, responsibilities, and companies he was working for, and then obviously where Grown Rogue sat. But getting him to come on board and lead New York for us has just been amazing. Michael brings deep industry roots and really, and most importantly, embodies our culture and our passion for excellence.
Another recent addition to our team is Neha Ganit, who joined us a few months ago as our Corporate Controller, and she's already providing just a much needed level of support to our accounting team, just bringing a level of experience and knowledge that' s going to be very critical during this period of growth for the company. Eamon McGetrick, who has been instrumental for us the last year. Anyone on this call who's met Eamon, his passion and intensity and knowledge just is without question. It's one of the cool stories kind of inside of Grown Rogue in terms of how we've been growing the business, but also growing the people who have been with us for years.
I think Eamon started with us four or five years ago as a grow tech, quickly moved up through the org, getting into fertigation, then became our Director of Cultivation in Oregon before recently being promoted to our National Director of Cultivation to support the rollouts in our new states this year. Eamon's just been a beast. He was on the ground in Illinois for months as we set up that production, and then I think literally flew to New York within 48 hours of signing the first set of agreements and has been on the ground out there ever since. Just a big thank you to Eamon and all that he's doing. The other person I want to highlight is Jordan Storms, goes by Jordy.
Another kind of standout inside the org who I think started with us, again, three, four, five years ago as a trimmer, and really has just been driving the training and execution inside of our post-harvest practices and really getting into the weeds for, no pun intended, of like, with our trim teams, the bucking teams, like how do they do that and do we spin up these new people under our standards to really preserve the handling and the quality of our product. The list could go on and on. I won't bore you guys with an hour of talking about our amazing team, but expect that to be a part of our calls going forward, just looking at what our team is doing and how they're performing. I want to leave everyone with just a little bit on where we're going.
It's kind of, I wouldn't say it's crazy, because this is kind of the roadmap that we've put in front of us, but we're now operating a six-state footprint. While we have a ton of execution to get right, it's pretty amazing and should have a material improvement in our financial performance in 2027, whereas you'll see from our guidance, reflects 50% revenue growth and about 100% Adjusted EBITDA.
I want to be clear, this has no contribution from New York yet, which time will tell, but based on what we've seen, based on the history there, arguably New York is going to become the largest market in our portfolio. As you've seen over the years with Grown Rogue, our foundation has been set, right? High-quality, low-cost indoor flower production. Our performance on those fronts in Oregon and Michigan speak for themselves.
You can look at the numbers, you can look at the yields, you can look at the costs, but the real test for Grown Rogue is, A, can we translate that performance into our new markets, which we're very confident we will, but B, as we take that foundation and we really tie the brand and our engagement with our customer to that.
We' ve been talking more recently about that on our previous calls. We've been investing on it inside the company, but it's a big kind of continuous renewed focus on that portion of our business, really to get into, how do our brands resonate? How does the customer view us? Do we live up to that consistency and quality that they can rely upon? I think when we hit that, it's going to be a pretty amazing outcome.
Our goal has always to become the leading independent flower company in the space, not necessarily the biggest, and we're well on our way. The six-state portfolio, the fact that I think is potentially understated is that we control all of that production, which allows us to ensure the passion and quality standards that we hold ourselves to is mandated and just not requested from a licensing partner, or some other process where we don't have that ability to just really ensure that quality and the genetics and the things that we do really well kind of come through. Very excited about that.
Sarah and I started Grown Rogue, it's kind of wild, 10 years ago, just like a couple weeks ago. We' ve never been more excited about our team, our business, and the future than we' re today. Super excited and appreciate everyone's kind of time and journey with us. 2026 has been a big year of growth. 2027 is going to be a pretty amazing year for the organization, and just super excited for the team and what we're going to do. With that, I will pass it over to Josh Rosen.
All right. Thanks, Obie Strickler. On last quarter's call, I led with a story about a deal we got outbid on in Massachusetts as a way of saying we're active, but disciplined. Sometimes timing is everything. The Friday we lost that deal was in May, and the very next Monday, I got a call about the opportunity I thought was the best fit for us all along, which was PharmaCann's New York operations.
Like Massachusetts, we had originally been outbid on New York too, but it was coming back to us with workable terms. As you can see from our August announcement, it's a fairly complex transaction given the multiple parties involved in the regulatory environment in New York. But I want to start with the industrial logic, because this gets right at why I joined Grown Rogue and where I see long-term value creation in the industry.
From our perspective, New York's regulated market is undersupplied with quality indoor flower, mostly because there just isn't enough indoor infrastructure. The adult-use rollout prioritized outdoor and greenhouse growers initially, in many ways, at the expense of the original medical license holders, PharmaCann among them. That's left a regulated market that skews heavily toward manufactured products like vapes and edibles, which for those who know the market, are highly competitive categories in New York.
But in indoor flower, we believe the illicit market is still dominant, and the operators with better indoor infrastructure in New York, among them GTI, Curaleaf, and Vireo, have started doing very well over the past several quarters. With more than 20 million people, plus a huge number of visitors, this is an incredibly deep consumer market, and it maps really well to our core competency of producing great flower.
Another thing about New York is it has a large and growing number of dispensaries, more than 700 now, with a regulatory regime that's prevented heavy consolidation. That comes with some challenges around the number of customers and at times creditworthiness. But in that way, it also looks a lot like our oldest markets, Oregon and Michigan. We know how to serve a large number of smaller doors. In a market like that, retailers don't control the supply chain the way they do in more consolidated markets. The last piece of the logic for us, which I'll come back to in future quarters, and Obie Strickler just referenced, is the brand. Historically, we've been more of a sales-driven producer than a marketing-driven one, largely because of how Oregon and Michigan are structured.
That's a big part of why you've heard us talk so much about efficiency and low cost. That's shifting in New Jersey, where the brand is resonating. As Obie Strickler just referenced, about everything we sell goes out as branded packaged product. For us, though, the brand is really about sharing our passion for great flower with more people and putting the customer first. We think New York can be New Jersey on steroids for that. Tying back to August, a quick refresher on the structure in New York. We formed Grown Rogue New York, which we own 51% of, alongside a capital partner who put in $10 million of preferred equity for the other 49% and committed another $5 million term loan.
That's against roughly $12 million of estimated total project costs, including the purchase price, some capital expenditures, and working capital, and with a cushion, called the contingency. Grown Rogue New York then signed a Goods and Services Agreement with PharmaCann of New York, which lets us support the operations in the interim, along with a secured loan of up to $9 million to fund the transition.
That $9 million came out of the initial $10 million. We became the direct tenant to Innovative Industrial Properties at the Hamptonburgh facility. The point of all that was to keep the business from shutting down while we finalize the purchase agreements and go through regulatory approval, and to do it with limited risk to Grown Rogue's balance sheet. Turning to where we a re today, we're working through what I believe and hope are the final details of the purchase agreements.
In August, we said four weeks, and it has taken longer than we anticipated. I now expect them to be executed by the end of this month, hopefully sooner. In the meantime, with the Goods and Services Agreement in place, we've been actively supporting PharmaCann of New York's operations, including their former Verilife stores. As Obie Strickler mentioned, we replanted the Hamptonburgh facility, with the first harvest expected in December. For context, before production slowed early this year, that facility was producing close to 2,000 pounds of flower a month, mapping to Obie's point earlier. On retail, when our agreement started, the Verilife stores were working through PharmaCann's inventory with very aggressive discounting and limited third-party product. They were basically converting inventory to cash as fast as they could while facing a shutdown. We've proactively restocked third-party product.
Partly, that was a necessity, since PharmaCann's in-house inventory was nearly gone, but it is also how we think about retail. Put the customer and the products they want first, rather than prioritizing our own vertical sales. We've also been working with PharmaCann to transition the point of sale systems, which is now largely complete. Overall, our expectations remain consistent with what we laid out in August.
As a reminder, that included about $20 million in annual cost savings that we identified, which we expect to implement over the first six months and is in motion. It included the New York operations becoming after-tax operating cash flow positive within nine months, and after-tax cash flow from operations of roughly $600,000 a month within 18 months. Most importantly, we believe New York meets or exceeds our hurdle of returns on incremental invested capital of greater than 75%.
We will continue to update investors at the important milestones. The next legal step, as I mentioned, is executing the purchase agreements. Under the services agreement, we've already started the required regulatory disclosures, and we're hopeful we will receive approval from the regulator in the first quarter of next year. To add to Obie's comments about being stretched, we are also building out our support teams. This is a heavy lift for what has historically been a very lean operation. We' ll not lose our entrepreneurial scrappiness, but we need to make sure we have the internal resources to properly support our local teams as they add value in their markets.
Some of you' ve heard me say previously that I view headquarters and corporate as a tax on the local businesses we run. We, on this call, need to do our part to add value. Last from me, and maybe this point goes without saying at this juncture, but my strategy and business development focus is entirely on using my experience and relationships to support the markets we are already in. We' ve a lot to digest and execute. With that, I'll hand it over to Andrew Marchington.
Thank you, Josh Rosen. I want to start off by explaining the write-off we took this quarter for Rogue EBC in Illinois. This was largely an accounting decision as a result of what was somewhat of an unclear path forward with this asset. We made the strategic decision to pivot to the Dwight facility based on the speed and cost to get to market, and we still stand behind that. This did leave Rogue EBC's facility and license on our balance sheet. This didn't really qualify as a discontinued operation or an asset held for sale, so the most appropriate accounting path forward was to record the consideration, impaired license, and any existing assets, and the lease asset. We're currently assessing various options for monetizing what we can, and we'll update further when something materializes.
Next, I want to highlight further to what Josh Rosen just stated, the heavy lift we foresee with the anticipated New York acquisition. I anticipate Grown Rogue will start consolidating PharmaCann of New York upon execution of the purchase agreements, which, as he stated, we believe is imminent. This comes with some challenges for our back office. First, we're drinking from a fire hose to work with PharmaCann's existing people and systems. For Grown Rogue, this will include our first consolidation of retail and manufacturing operations. As Josh Rosen noted, we've already replaced the point of sale system to improve customer experience, but with that comes incremental accounting, procurement, and inventory workload that we' ve to balance.
Secondly, PCNY does not have standalone back office support and relies heavily upon PharmaCann's corporate team, which has been managing through the sale of their assets for over a year, and at this point, are spread quite thin. We've already begun the process of augmenting the support structure both inside and outside of PCNY. On the team side, we recently added a corporate controller, as Obie Strickler noted, as well as some additional accounting and HR support staff. We have some additional recruiting both to support Grown Rogue's growth in the Midwest, but also in New York, as I just alluded to, as there' s a lack of dedicated New York support staff, and it is a sizable operation.
I'll end by noting that I'm excited to take on these challenges and support our growth, having personal experience with the retail side of the industry and being a big believer in building around an Oregon foundation. I'm excited about the future and aware of the fact that this period of growth will bring us a number of challenges. With that, I'll send it back to Obie Strickler.
Great. Thanks, you guys. With that, we'll open it up to questions.
Thank you. Ladies and gentlemen, we will now begin the question and answer session. Should you have a question, please press star followed by the number one on your touchtone phone, and you will hear a prompt that your hand has been raised. If you wish to decline from the polling process, please press star followed by the number two. Once again, if you wish to ask a question, please press star one on your touchtone phone. Again, if you would like to ask a question, please press star one on your telephone keypad. There are no questions at this time. I will now turn the call over to Mr. Obie Strickler. Please continue.
All right. Thank you very much, and appreciate everyone who joined and listened. We' re going to get back to work and put our heads down and keep on executing. Thanks everyone for supporting us, and again, looking forward to the future and just cannot be more excited about what's sitting in front of us and where we are heading. Appreciate everyone. Thank you.
Ladies and gentlemen, this concludes today's conference call. Thank you all for participating. You may now disconnect.